Indian Journal of Nephrology Home 

SPECIAL ARTICLE
[View FULLTEXT] [Download PDF]
Year : 2021  |  Volume : 31  |  Issue : 2  |  Page : 89--91

NOTTO COVID-19 vaccine guidelines for transplant recipients

Vivek B Kute1, Sanjay K Agarwal2, Jai Prakash3, Sandeep Guleria4, Sunil Shroff5, Ashish Sharma6, Prem Varma7, Narayan Prasad8, Manisha Sahay9, Subhash Gupta10, S Sudhindran11, Kewal Krishan12, Vasanthi Ramesh13, Sunil Kumar14 
1 Department of Nephrology, Institute of Kidney Diseases and Research Center and Dr. H L Trivedi Institute of Transplantation Sciences (IKDRC-ITS), Ahmedabad, Gujarat, India
2 Department of Nephrology, All India Institute of Medical Sciences, Delhi, India
3 Department of Nephrology, Banaras Hindu University, Varanasi, Uttar Pradesh, India
4 Department of Transplantation Surgery, Apollo Hospital, Delhi, India
5 Managing, Trustee, MOHAN Foundation, Chennai, Tamil Nadu, India
6 Department of Transplant Surgery, The Postgraduate Institute of Medical Education and Research (PGIMER), Chandigarh, India
7 Department of Nephrology, Venkateshwar Hospital, Delhi, India
8 Department of Nephrology, Sanjay Gandhi Postgraduate Institute of Medical Sciences, Lucknow, Uttar Pradesh, India
9 Department of Nephrology, Osmania Medical College, Hyderabad, Telangana, India
10 Department of Liver Transplant Surgery, Max Center of Liver and Biliary Sciences at Max Hospital, Saket, Delhi, India
11 Clinical Professor in Transplantation and Gastrointestinal Surgery, Amrita Institute of Medical Sciences and Research Centre, Kochi, Kerala, India
12 Department of Cardiovascular Surgery, Max super specialty Hospital, Saket, New Delhi, India
13 National Organ and Tissue Transplant Organization, New Delhi, India
14 Director General of Health Services, New Delhi, India

Correspondence Address:
Dr. Vasanthi Ramesh
National Organ and Tissue Transplant Organization, 4th Floor, National Institute of Pathology, NIOP Building, Safdarjung Hospital Campus, New Delhi - 110 029
India

In December 2019, novel coronavirus (SARS-CoV-2) infection started in Wuhan and resulted in a pandemic within a few weeks' time. Organ transplant recipients being at a risk for more severe COVID-19 if they get SARS CoV-2 viral infection, COVID-19 vaccine has a significant role in these patients. The vaccine is a safer way to help build protection and would either prevent COVID-19 infection or at least diminish the severity of the disease. It would also reduce the risk of the continuing transmission and enhance herd immunity. Immuno-compromised patients should not receive live vaccines as they can cause vaccine-related disease and hence the guidelines suggest that all transplant recipients should receive age-appropriate 'inactivated vaccine' as recommended for general population. Though trials have not been undertaken on transplant recipients, efficacy and safety of COVID-19 vaccine have been scientifically documented for few vaccines among the general population.

How to cite this article:
Kute VB, Agarwal SK, Prakash J, Guleria S, Shroff S, Sharma A, Varma P, Prasad N, Sahay M, Gupta S, Sudhindran S, Krishan K, Ramesh V, Kumar S. NOTTO COVID-19 vaccine guidelines for transplant recipients.Indian J Nephrol 2021;31:89-91

How to cite this URL:
Kute VB, Agarwal SK, Prakash J, Guleria S, Shroff S, Sharma A, Varma P, Prasad N, Sahay M, Gupta S, Sudhindran S, Krishan K, Ramesh V, Kumar S. NOTTO COVID-19 vaccine guidelines for transplant recipients. Indian J Nephrol [serial online] 2021 [cited 2021 Jun 19 ];31:89-91
Available from: https://www.indianjnephrol.org/article.asp?issn=0971-4065;year=2021;volume=31;issue=2;spage=89;epage=91;aulast=Kute;type=0